\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ continue\\ annual\\ mammograms\ \(0\)\
\-\ parenchymal\\ redistribution\\ with\\ typical\\ \\"swirling\\ pattern\\"\\ 90\\%\ \(0\)\
\-\ elevation\\ of\\ nipple\\ 85\\%\ \(0\)\
\-\ ca\\+\\+\\ around\\ nac\\ 25\\%\ \(0\)\
\-\ oil\\ cysts\\/fat\\ necrosis\\ 20\\%\ \(0\)\
\-\ retroareolar\\ fibrotic\\ bands\\ 20\\%\ \(0\)\
\-\ areolar\\/skin\\ thickening\\ 7\\%\ \(0\)\
\-\ discontinuity\\ of\\ retroareolar\\ ducts\ \(0\)\
\-\ reduction\\ mammoplasty\ \(12\)\
\-\ knowing\\ the\\ predictable\\ changes\\ after\\ reduction\\ mammoplasty\\ can\\ help\\ reduce\\ biopsies\\ for\\ findings\\ mistaken\\ for\\ increased\\ densities\\,\\ masses\\,\\ or\\ calcifications\\.\\ \\ however\\,\\ women\\ who\\ have\\ undergone\\ reduction\\ mammoplasty\\ still\\ have\\ the\\ same\\ risk\\ of\\ developing\\ breast\\ cancer\\ and\\ may\\ need\\ to\\ undergo\\ biopsy\\ if\\ truly\\ suspicious\\ findings\\ are\\ present\\.\ \(0\)\
\-\ 44\\ year\\ old\\ woman\\ for\\ screening\\ mammogram\ \(1\)\
\-\ knowing\\ the\\ predictable\\ changes\\ after\\ reduction\\ mammoplasty\\ can\\ help\\ reduce\\ biopsies\\ for\\ findings\\ mistaken\\ for\\ increased\\ densities\\,\\ masses\\,\\ or\\ calcifications\\.\\ \\ however\\,\\ women\\ who\\ have\\ undergone\\ reduction\\ mammoplasty\\ still\\ have\\ the\\ same\\ risk\\ of\\ developing\\ breast\\ cancer\\ and\\ may\\ need\\ to\\ undergo\\ biopsy\\ if\\ truly\\ suspicious\\ findings\\ are\\ present\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ mammoplasty\\:\\ 0\\.2187773335958976\ \(0\)\
\-\ reduction\\:\\ 0\\.12828110449632013\ \(0\)\
\-\ predictable\\:\\ 0\\.09463979697893768\ \(0\)\
\-\ knowing\\:\\ 0\\.09179720396856558\ \(0\)\
\-\ truly\\:\\ 0\\.08751093343835904\ \(0\)\
\-\ retroareolar\\:\\ 0\\.08580989658963901\ \(0\)\
\-\ \\%\\:\\ 0\\.07617787388583468\ \(0\)\
\-\ undergone\\:\\ 0\\.07235699628073056\ \(0\)\
\-\ mistaken\\:\\ 0\\.07129481017959614\ \(0\)\
\-\ biopsies\\:\\ 0\\.07031441475111044\ \(0\)\
\-\ reduce\\:\\ 0\\.06148451436181177\ \(0\)\
\-\ densities\\:\\ 0\\.06035644560586979\ \(0\)\
\-\ developing\\:\\ 0\\.05696449684220146\ \(0\)\
\-\ nac\\:\\ 0\\.05614979887876751\ \(0\)\
\-\ cysts\\/fat\\:\\ 0\\.05614979887876751\ \(0\)\
\-\ areolar\\/skin\\:\\ 0\\.05614979887876751\ \(0\)\
\-\ undergo\\:\\ 0\\.05526345999348142\ \(0\)\
\-\ help\\:\\ 0\\.05428842716389755\ \(0\)\
\-\ need\\:\\ 0\\.05428842716389755\ \(0\)\
\-\ women\\:\\ 0\\.05289273031661696\ \(0\)\
\-\ suspicious\\:\\ 0\\.05242086698310933\ \(0\)\
\-\ still\\:\\ 0\\.051854602491761125\ \(0\)\
\-\ redistribution\\:\\ 0\\.04915226837769674\ \(0\)\
\-\ have\\:\\ 0\\.04714491919401508\ \(0\)\
\-\ findings\\:\\ 0\\.046339794542419356\ \(0\)\
\-\ same\\:\\ 0\\.04486896304766887\ \(0\)\
\-\ ca\\+\\+\\:\\ 0\\.04375546671917952\ \(0\)\
\-\ swirling\\:\\ 0\\.040876580580688715\ \(0\)\
\-\ calcifications\\:\\ 0\\.040473423625894935\ \(0\)\
\-\ breast\\:\\ 0\\.04015997380675863\ \(0\)\
\-\ risk\\:\\ 0\\.039429384042790915\ \(0\)\
\-\ oil\\:\\ 0\\.03934051652453019\ \(0\)\
\-\ 20\\:\\ 0\\.03914032147970721\ \(0\)\
\-\ fibrotic\\:\\ 0\\.03890107148321203\ \(0\)\
\-\ discontinuity\\:\\ 0\\.03890107148321203\ \(0\)\
\-\ biopsy\\:\\ 0\\.03862029607180587\ \(0\)\
\-\ masses\\:\\ 0\\.03679735538848519\ \(0\)\
\-\ cancer\\:\\ 0\\.035785544768977905\ \(0\)\
\-\ mammograms\\:\\ 0\\.03448612128856269\ \(0\)\
\-\ bands\\:\\ 0\\.03249647361313497\ \(0\)\
\-\ nipple\\:\\ 0\\.032342986023459426\ \(0\)\
\-\ ducts\\:\\ 0\\.03123245489514874\ \(0\)\
\-\ changes\\:\\ 0\\.031198063391529435\ \(0\)\
\-\ 85\\:\\ 0\\.030397879975362727\ \(0\)\
\-\ however\\:\\ 0\\.030310421090408542\ \(0\)\
\-\ if\\:\\ 0\\.029538132914403\ \(0\)\
\-\ continue\\:\\ 0\\.02936831722659575\ \(0\)\
\-\ mammogram\\:\\ 0\\.028400061129152273\ \(0\)\
\-\ who\\:\\ 0\\.028381763173779644\ \(0\)\
\-\ 44\\:\\ 0\\.02792803582881009\ \(0\)\
\-\ annual\\:\\ 0\\.0272797384128232\ \(0\)\
\-\ elevation\\:\\ 0\\.02688151957854719\ \(0\)\
\-\ parenchymal\\:\\ 0\\.026754126796976044\ \(0\)\
\-\ increased\\:\\ 0\\.026630379385982877\ \(0\)\
\-\ 90\\:\\ 0\\.02565622089926403\ \(0\)\
\-\ can\\:\\ 0\\.024690730604701526\ \(0\)\
\-\ present\\:\\ 0\\.024586098776199758\ \(0\)\
\-\ may\\:\\ 0\\.023876794508256357\ \(0\)\
\-\ for\\:\\ 0\\.02322000473384443\ \(0\)\
\-\ screening\\:\\ 0\\.02321677980209138\ \(0\)\
\-\ around\\:\\ 0\\.022662567209800744\ \(0\)\
\-\ after\\:\\ 0\\.022522308313493025\ \(0\)\
\-\ 25\\:\\ 0\\.02200144113539537\ \(0\)\
\-\ typical\\:\\ 0\\.02182450123662419\ \(0\)\
\-\ necrosis\\:\\ 0\\.021484717920029966\ \(0\)\
\-\ 7\\:\\ 0\\.020855126616611926\ \(0\)\
\-\ pattern\\:\\ 0\\.020805365217014513\ \(0\)\
\-\ n\\/a\\:\\ 0\\.019714692021395457\ \(0\)\
\-\ thickening\\:\\ 0\\.018449838023524533\ \(0\)\
\-\ are\\:\\ 0\\.014839157611842062\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.013376656290648516\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.013119423579504732\ \(0\)\
\-\ or\\:\\ 0\\.01275825157915551\ \(0\)\
\-\ woman\\:\\ 0\\.012572630238782844\ \(0\)\
\-\ \\,\\:\\ 0\\.010345607599386778\ \(0\)\
\-\ year\\:\\ 0\\.006089842479445317\ \(0\)\
\-\ old\\:\\ 0\\.0055728318271481185\ \(0\)\
\-\ to\\:\\ 0\\.005440358069337405\ \(0\)\
\-\ the\\:\\ 0\\.0035222747695191287\ \(0\)\
\-\ of\\:\\ 0\\.002968249701859578\ \(0\)\
\-\ and\\:\\ 0\\.002293108353276668\ \(0\)\
\-\ \\.\\:\\ 0\\.0009044467795502236\ \(0\)\
\-\ with\\:\\ 0\\.0007452495292349665\ \(0\)\
